Your prescribing provider and pharmacist should both be aware of all medications in your regimen
In the LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results), researchers found that liraglutide reduced the risk of cardiovascular events in diabetic patients, including heart attack, stroke, and cardiovascular death, by 13% compared to placebo
Specialty pharmacy / patient advocacy : Daily checks on formulary update pages for fastest awareness
Evidence for a common pattern of ligand-receptor interaction
Part Four: Biosimilar Competition A Different Animal Why Biologics Dont Have Cliffs The difference between a small-molecule drug and a biologic runs deeper than chemistry
For many hypothyroid patients, that more careful approach is what makes the medication both usable, useful, and ultimately successful for you